Fierce Biotech News & Reports
WEBBiopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
Labcorp, Quest Diagnostics back PreciseDx's $20.7M series B
WEBBy Heather Landi Aug 21, 2024 11:00am. PreciseDx funding round venture capital (VC) Cancer. Cancer diagnostics startup PreciseDx picked up $20.7 million in series B funding as it ramps up ...
Genentech to close cancer immunology research department
WEBBy Angus Liu Aug 16, 2024 11:08am. Roche Genentech immuno-oncology layoffs. Genentech will close its cancer immunology research department, and unit head and renowned cell biologist Ira Mellman ...
The top biotech hubs in 2022 - Fierce Biotech
WEBBy Annalee Armstrong Jul 5, 2022 12:00am. startups real estate venture capital (VC) small biotechs. Top cities for biotechs include Boston, San Francisco, San Diego and a little corner of North ...
ASCO: Jazz shares 'unprecedented' biliary tract cancer data
WEBJun 1, 2024 · As zanidatamab awaits an FDA approval decision, Jazz Pharmaceuticals is sharing long-term phase 2b data in advanced biliary tract cancer (BTC) for the HER2-targeted bispecific antibody.. The data ...
Gilead gives up on $4.9B antibody magrolimab - Fierce Biotech
WEBApr 26, 2024 · Gilead Sciences solid tumor R&D monoclonal antibody. A $4.9 billion hole has appeared in Gilead Sciences' pipeline. After years of setbacks, the Big Biotech dealt a final blow to its anti-CD47 ...
AstraZeneca launches company to share digital trial expertise
WEBBy James Waldron Nov 20, 2023 8:40am. AstraZeneca contract research organization decentralized trials machine learning. AstraZeneca has launched a new company to allow CROs and fellow Big Pharmas ...
Bristol Myers pays $800M upfront for antibody-drug conjugate
WEBDec 12, 2023 · Bristol Myers Squibb has filled the antibody-drug conjugate (ADC) shaped hole in its pipeline by following the increasingly well-trodden path to China, handing SystImmune $800 million upfront for ...
Novartis, Versant hope to repeat Chinook’s success with Borealis
WEBAug 22, 2024 · Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M. Novartis’ $3.2 billion deal for Chinook Therapeutics gave the Swiss Big Pharma such a taste for ...
J&J beefs up ADC pipeline by acquiring Ambrx for $2B - Fierce …
WEBJan 8, 2024 · Not to be outdone by its Big Pharma peers, Johnson & Johnson has fattened up its antibody-drug conjugate (ADC) pipeline via the acquisition of Ambrx Biopharma for $2 billion. By paying $28 per ...